Oxford Biomedica 주식 주식분석 | 주식가격 | 뉴스 | OXB.L | GB00BDFBVT43 | A2JLRX

날짜	Oxford Biomedica 주식 가격
	0 undefined
	4.20 undefined
	4.15 undefined
	4.15 undefined
	4.05 undefined
	4.07 undefined
	4.07 undefined
	4.02 undefined
	3.92 undefined
	4.10 undefined
	4.10 undefined
	4.12 undefined
	4.08 undefined
	4.16 undefined
	4.23 undefined
	4.24 undefined
	4.20 undefined
	4.20 undefined
	4.19 undefined
	4.22 undefined

날짜	Oxford Biomedica 매출	Oxford Biomedica EBIT	Oxford Biomedica 이익
2028e	253.35 백만 undefined	25.85 백만 undefined	-5.24 백만 undefined
2027e	240.65 백만 undefined	18.59 백만 undefined	39.06 백만 undefined
2026e	218.16 백만 undefined	6.94 백만 undefined	-4.2 백만 undefined
2025e	172.23 백만 undefined	-17.49 백만 undefined	-26.13 백만 undefined
2024e	133.24 백만 undefined	-41.22 백만 undefined	-43.48 백만 undefined
2023	89.54 백만 undefined	-85.98 백만 undefined	-157.49 백만 undefined
2022	139.99 백만 undefined	-51.56 백만 undefined	-39.16 백만 undefined
2021	142.8 백만 undefined	20.93 백만 undefined	19.01 백만 undefined
2020	87.73 백만 undefined	-4.86 백만 undefined	-6.25 백만 undefined
2019	64.06 백만 undefined	-12.58 백만 undefined	-16.07 백만 undefined
2018	66.78 백만 undefined	7.93 백만 undefined	7.54 백만 undefined
2017	37.59 백만 undefined	-7.97 백만 undefined	-9.02 백만 undefined
2016	27.78 백만 undefined	-11.31 백만 undefined	-16.64 백만 undefined
2015	15.91 백만 undefined	-14.08 백만 undefined	-13.02 백만 undefined
2014	13.62 백만 undefined	-10.61 백만 undefined	-8.66 백만 undefined
2013	5.38 백만 undefined	-12.82 백만 undefined	-11.1 백만 undefined
2012	7.76 백만 undefined	-10.49 백만 undefined	-8.73 백만 undefined
2011	7.72 백만 undefined	-11.3 백만 undefined	-12.63 백만 undefined
2010	11.15 백만 undefined	-8.06 백만 undefined	-10.29 백만 undefined
2009	19.12 백만 undefined	-2.17 백만 undefined	-3.52 백만 undefined
2008	18.39 백만 undefined	-9.11 백만 undefined	-10.04 백만 undefined
2007	7.22 백만 undefined	-19.49 백만 undefined	-15.29 백만 undefined
2006	760,000 undefined	-21.1 백만 undefined	-17.63 백만 undefined
2005	820,000 undefined	-11.23 백만 undefined	-9.09 백만 undefined
2004	500,000 undefined	-12.65 백만 undefined	-10.61 백만 undefined

	매출	EBIT	이익
2004	500,000 GBP	-12.65 백만 GBP	-10.61 백만 GBP
2005	820,000 GBP	-11.23 백만 GBP	-9.09 백만 GBP
2006	760,000 GBP	-21.1 백만 GBP	-17.63 백만 GBP
2007	7.22 백만 GBP	-19.49 백만 GBP	-15.29 백만 GBP
2008	18.39 백만 GBP	-9.11 백만 GBP	-10.04 백만 GBP
2009	19.12 백만 GBP	-2.17 백만 GBP	-3.52 백만 GBP
2010	11.15 백만 GBP	-8.06 백만 GBP	-10.29 백만 GBP
2011	7.72 백만 GBP	-11.3 백만 GBP	-12.63 백만 GBP
2012	7.76 백만 GBP	-10.49 백만 GBP	-8.73 백만 GBP
2013	5.38 백만 GBP	-12.82 백만 GBP	-11.1 백만 GBP
2014	13.62 백만 GBP	-10.61 백만 GBP	-8.66 백만 GBP
2015	15.91 백만 GBP	-14.08 백만 GBP	-13.02 백만 GBP
2016	27.78 백만 GBP	-11.31 백만 GBP	-16.64 백만 GBP
2017	37.59 백만 GBP	-7.97 백만 GBP	-9.02 백만 GBP
2018	66.78 백만 GBP	7.93 백만 GBP	7.54 백만 GBP
2019	64.06 백만 GBP	-12.58 백만 GBP	-16.07 백만 GBP
2020	87.73 백만 GBP	-4.86 백만 GBP	-6.25 백만 GBP
2021	142.8 백만 GBP	20.93 백만 GBP	19.01 백만 GBP
2022	139.99 백만 GBP	-51.56 백만 GBP	-39.16 백만 GBP
2023	89.54 백만 GBP	-85.98 백만 GBP	-157.49 백만 GBP
2024e	133.24 백만 GBP	-41.22 백만 GBP	-43.48 백만 GBP
2025e	172.23 백만 GBP	-17.49 백만 GBP	-26.13 백만 GBP
2026e	218.16 백만 GBP	6.94 백만 GBP	-4.2 백만 GBP
2027e	240.65 백만 GBP	18.59 백만 GBP	39.06 백만 GBP
2028e	253.35 백만 GBP	25.85 백만 GBP	-5.24 백만 GBP

Oxford Biomedica 브루토마진	Oxford Biomedica 이익 마진	Oxford Biomedica EBIT-마진	Oxford Biomedica 이익 마진
2028e	44.37 %	10.2 %	-2.07 %
2027e	44.37 %	7.72 %	16.23 %
2026e	44.37 %	3.18 %	-1.92 %
2025e	44.37 %	-10.15 %	-15.17 %
2024e	44.37 %	-30.94 %	-32.63 %
2023	44.37 %	-96.03 %	-175.89 %
2022	49.42 %	-36.83 %	-27.97 %
2021	57.87 %	14.66 %	13.31 %
2020	52.52 %	-5.54 %	-7.12 %
2019	44.24 %	-19.64 %	-25.08 %
2018	65.91 %	11.88 %	11.29 %
2017	50.94 %	-21.19 %	-23.99 %
2016	57.39 %	-40.73 %	-59.91 %
2015	63.3 %	-88.52 %	-81.83 %
2014	67.57 %	-77.93 %	-63.6 %
2013	78.81 %	-238.29 %	-206.32 %
2012	91.37 %	-135.18 %	-112.5 %
2011	92.75 %	-146.37 %	-163.6 %
2010	105.38 %	-72.29 %	-92.29 %
2009	97.7 %	-11.35 %	-18.41 %
2008	92.99 %	-49.54 %	-54.59 %
2007	93.77 %	-269.94 %	-211.77 %
2006	100 %	-2,776.32 %	-2,319.74 %
2005	44.37 %	-1,369.51 %	-1,108.54 %
2004	44.37 %	-2,530 %	-2,122 %

	브루토마진	EBIT-마진	이익 마진
2004	44.37 %	-2,530 %	-2,122 %
2005	44.37 %	-1,369.51 %	-1,108.54 %
2006	100 %	-2,776.32 %	-2,319.74 %
2007	93.77 %	-269.94 %	-211.77 %
2008	92.99 %	-49.54 %	-54.59 %
2009	97.7 %	-11.35 %	-18.41 %
2010	105.38 %	-72.29 %	-92.29 %
2011	92.75 %	-146.37 %	-163.6 %
2012	91.37 %	-135.18 %	-112.5 %
2013	78.81 %	-238.29 %	-206.32 %
2014	67.57 %	-77.93 %	-63.6 %
2015	63.3 %	-88.52 %	-81.83 %
2016	57.39 %	-40.73 %	-59.91 %
2017	50.94 %	-21.19 %	-23.99 %
2018	65.91 %	11.88 %	11.29 %
2019	44.24 %	-19.64 %	-25.08 %
2020	52.52 %	-5.54 %	-7.12 %
2021	57.87 %	14.66 %	13.31 %
2022	49.42 %	-36.83 %	-27.97 %
2023	44.37 %	-96.03 %	-175.89 %
2024e	44.37 %	-30.94 %	-32.63 %
2025e	44.37 %	-10.15 %	-15.17 %
2026e	44.37 %	3.18 %	-1.92 %
2027e	44.37 %	7.72 %	16.23 %
2028e	44.37 %	10.2 %	-2.07 %

날짜	Oxford Biomedica 주당 매출	Oxford Biomedica EBIT 당 주식	Oxford Biomedica 주당 이익
2028e	2.39 undefined	0 undefined	-0.05 undefined
2027e	2.27 undefined	0 undefined	0.37 undefined
2026e	2.06 undefined	0 undefined	-0.04 undefined
2025e	1.63 undefined	0 undefined	-0.25 undefined
2024e	1.26 undefined	0 undefined	-0.41 undefined
2023	0.93 undefined	-0.89 undefined	-1.63 undefined
2022	1.48 undefined	-0.54 undefined	-0.41 undefined
2021	1.67 undefined	0.24 undefined	0.22 undefined
2020	1.1 undefined	-0.06 undefined	-0.08 undefined
2019	0.88 undefined	-0.17 undefined	-0.22 undefined
2018	0.96 undefined	0.11 undefined	0.11 undefined
2017	0.61 undefined	-0.13 undefined	-0.15 undefined
2016	0.5 undefined	-0.2 undefined	-0.3 undefined
2015	0.31 undefined	-0.27 undefined	-0.25 undefined
2014	0.34 undefined	-0.26 undefined	-0.21 undefined
2013	0.19 undefined	-0.45 undefined	-0.39 undefined
2012	0.34 undefined	-0.46 undefined	-0.38 undefined
2011	0.41 undefined	-0.6 undefined	-0.68 undefined
2010	1.02 undefined	-0.74 undefined	-0.95 undefined
2009	1.67 undefined	-0.19 undefined	-0.31 undefined
2008	1.62 undefined	-0.8 undefined	-0.89 undefined
2007	0.65 undefined	-1.75 undefined	-1.37 undefined
2006	0.07 undefined	-2 undefined	-1.67 undefined
2005	0.1 undefined	-1.4 undefined	-1.13 undefined
2004	0.06 undefined	-1.6 undefined	-1.34 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	0.06 GBP	-1.6 GBP	-1.34 GBP
2005	0.1 GBP	-1.4 GBP	-1.13 GBP
2006	0.07 GBP	-2 GBP	-1.67 GBP
2007	0.65 GBP	-1.75 GBP	-1.37 GBP
2008	1.62 GBP	-0.8 GBP	-0.89 GBP
2009	1.67 GBP	-0.19 GBP	-0.31 GBP
2010	1.02 GBP	-0.74 GBP	-0.95 GBP
2011	0.41 GBP	-0.6 GBP	-0.68 GBP
2012	0.34 GBP	-0.46 GBP	-0.38 GBP
2013	0.19 GBP	-0.45 GBP	-0.39 GBP
2014	0.34 GBP	-0.26 GBP	-0.21 GBP
2015	0.31 GBP	-0.27 GBP	-0.25 GBP
2016	0.5 GBP	-0.2 GBP	-0.3 GBP
2017	0.61 GBP	-0.13 GBP	-0.15 GBP
2018	0.96 GBP	0.11 GBP	0.11 GBP
2019	0.88 GBP	-0.17 GBP	-0.22 GBP
2020	1.1 GBP	-0.06 GBP	-0.08 GBP
2021	1.67 GBP	0.24 GBP	0.22 GBP
2022	1.48 GBP	-0.54 GBP	-0.41 GBP
2023	0.93 GBP	-0.89 GBP	-1.63 GBP
2024e	1.26 GBP	0 GBP	-0.41 GBP
2025e	1.63 GBP	0 GBP	-0.25 GBP
2026e	2.06 GBP	0 GBP	-0.04 GBP
2027e	2.27 GBP	0 GBP	0.37 GBP
2028e	2.39 GBP	0 GBP	-0.05 GBP

	주식 수량
2004	7.92 백만 Aktien
2005	8.04 백만 Aktien
2006	10.55 백만 Aktien
2007	11.14 백만 Aktien
2008	11.33 백만 Aktien
2009	11.42 백만 Aktien
2010	10.88 백만 Aktien
2011	18.7 백만 Aktien
2012	22.93 백만 Aktien
2013	28.32 백만 Aktien
2014	40.39 백만 Aktien
2015	51.4 백만 Aktien
2016	55.56 백만 Aktien
2017	61.91 백만 Aktien
2018	69.24 백만 Aktien
2019	72.71 백만 Aktien
2020	79.94 백만 Aktien
2021	85.64 백만 Aktien
2022	94.83 백만 Aktien
2023	96.56 백만 Aktien
2024e	96.56 백만 Aktien
2025e	96.56 백만 Aktien
2026e	96.56 백만 Aktien
2027e	96.56 백만 Aktien
2028e	96.56 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.4	-0.11 (73.82 %)	2023 Q4
-0.31	-0.5 (-60.4 %)	2023 Q2
-0.14	-0.14 (-1.82 %)	2022 Q4
-0.11	-0.27 (-141.5 %)	2022 Q2
0.08	0.02 (-80.76 %)	2021 Q4
0.07	0.21 (215.51 %)	2021 Q2
0.03	0.01 (-68.11 %)	2020 Q4
-0.02	-0.08 (-301.03 %)	2020 Q2
-0.09	-0.06 (29.19 %)	2019 Q4
0.05	-0.13 (-370.72 %)	2019 Q2
-0.03	0.03 (230.59 %)	2018 Q4
0.33	0.08 (-76.93 %)	2018 Q2
-0.2	-0.1 (52.71 %)	2017 Q4
-0.12	-0.06 (54.55 %)	2017 Q2
-0.15	-0.13 (16.28 %)	2016 Q4
-0.19	-0.18 (8.18 %)	2016 Q2
-0.15	-0.14 (9.58 %)	2015 Q4
-0.14	-0.12 (13.73 %)	2015 Q2
-0.12	-0.1 (15.61 %)	2014 Q4

%-지분	이름	주식	변경
11.37323 %	Novo Holdings A/S	12,048,802	0
10.86509 %	Institut Merieux SA	11,510,481	5,201,107
7.95393 %	Vulpes Investment Management Private Limited	8,426,390	0
6.76829 %	M&G Investment Management Ltd.	7,170,330	119,809
5.73796 %	Liontrust Investment Partners LLP	6,078,799	-838,958
3.87553 %	Fidelity Management & Research Company LLC	4,105,735	4,016,621
3.64200 %	BlackRock Advisors (UK) Limited	3,858,339	231,470
3.48300 %	Hargreaves Lansdown Asset Management Limited	3,689,888	256,641
3.19327 %	Serum Life Sciences Ltd	3,382,950	0
3.06341 %	Columbia Threadneedle Investments (UK)	3,245,381	61,653
2.91275 %	Lansdowne Partners (UK) LLP	3,085,765	2,382,375
2.83610 %	Vitruvian Partners LLP	3,004,567	0
2.81794 %	The Vanguard Group, Inc.	2,985,324	-171,167
2.73990 %	Shah (Sobhagchand Meghji Hirji)	2,902,652	-7,731
2.46891 %	BlackRock Investment Management (UK) Ltd.	2,615,567	28,206
1.40438 %	Norges Bank Investment Management (NBIM)	1,487,803	70,298
0.63208 %	Acadian Asset Management LLC	669,623	324,780
0.53343 %	Lombard Odier Asset Management (Europe) Ltd	565,118	565,118
0.42477 %	Oaktree Capital Management, L.P.	450,000	-150,000
0.41988 %	Vanguard Global Advisers LLC	444,825	0
0.41009 %	Legal & General Investment Management Ltd.	434,451	0
0.35096 %	Doliveux (Roch Frederic)	371,805	0
0.24457 %	BlackRock Life, Ltd.	259,098	259,098
0.23598 %	Royce Investment Partners	250,000	250,000
0.23538 %	Dawson (John)	249,366	0
0.22654 %	Sir A M D & Lady E V Gormley	240,000	80,000
0.22563 %	Close Brothers Asset Management	239,037	0
0.22236 %	Freeman (Robert M)	235,566	13,500
0.19135 %	River Global Investors LLP	202,713	39,326
0.16770 %	Watts (T)	177,662	177,662
0.16410 %	Janus Henderson Investors	173,852	111,596
0.15292 %	Crawford (Ward)	162,000	162,000
0.14159 %	Canaccord Genuity Wealth Management	150,000	0
0.13989 %	Mitrophanous (Kyriacos)	148,200	159
0.13836 %	Berry (Alexander)	146,580	146,580
0.13052 %	DZ PRIVATBANK S.A.	138,275	0
0.13052 %	Bellecapital AG	138,275	0
0.12960 %	abrdn Alternative Investments Limited	137,300	0
0.12507 %	LGT Bank (Schweiz) AG	132,500	0
0.11959 %	Platinum Asset Management	126,689	0
0.11495 %	Geode Capital Management, L.L.C.	121,776	2,156
0.11422 %	EFG Bank SA	121,000	105,000
0.11278 %	DBS Bank Ltd.	119,483	-8,717
0.10547 %	JPMorgan Asset Management U.K. Limited	111,733	-98
0.09631 %	Pine (Elliot)	102,027	29,302
0.09439 %	Lauxera Capital Partners	100,000	0
0.09163 %	Kilbey (Graham)	97,073	17,473
0.08259 %	Charnock (Colin)	87,500	21,500
0.07849 %	AFH Wealth Management	83,151	0
0.06768 %	Batchelor (Jeffery Tudor)	71,698	0
0.06721 %	California State Teachers Retirement System	71,199	2,799
0.06302 %	Birtles (Russell)	66,760	0
0.06253 %	Hopkins (Stephen Laurence)	66,246	0
0.05703 %	Page (Nicholas)	60,417	38,525
0.05676 %	Da'Silva (Carlos)	60,129	0
0.05598 %	State Street Global Advisors (UK) Ltd.	59,309	6,475
0.05557 %	abrdn Investments Limited	58,873	0
0.05190 %	Tallarigo (Lorenzo)	54,988	0
0.04724 %	Foster (Edward David)	50,046	7,209
0.04664 %	First Sentier Investors	49,406	49,406
0.04526 %	Hignett (Philip)	47,950	4,971
0.04452 %	DWS Investment GmbH	47,165	13,969
0.04385 %	Brompton Asset Management LLP	46,458	8,680
0.04365 %	Margetts Fund Management Limited	46,247	6,305
0.04339 %	Pink (Daemon Joseph)	45,967	45,967
0.04258 %	Pass (M)	45,114	0
0.03964 %	Harris (E)	41,993	-29,007
0.03831 %	Ninety One SA Pty Ltd.	40,590	40,590
0.03782 %	McKenzie (I)	40,063	-5,937
0.03776 %	Ostrum Asset Management	40,000	40,000
0.03773 %	Hayden (Michael Reuben)	39,973	0
0.03730 %	St. Galler Kantonalbank AG	39,516	0
0.03450 %	McKay (James Patrick)	36,546	5,415
0.03266 %	Da Silva (Carl)	34,596	16,545
0.03253 %	Cruickshank (N)	34,462	-4,718
0.03239 %	State Street Global Advisors (US)	34,309	-3,719
0.03209 %	Allspring Global Investments, LLC	33,997	0
0.03015 %	Calnan (Terence Arthur)	31,942	7,175
0.02997 %	Rose (William Marcus Henderson)	31,746	0
0.02863 %	Khan (Naheed)	30,333	30,333
0.02846 %	Abdul-Rahman (Ibrahim)	30,153	0
0.02818 %	Prescott (Ian Charles)	29,850	29,850
0.02748 %	Black (L)	29,113	0
0.02643 %	Birrell (Donald John)	28,000	0
0.02600 %	Harrop (Richard Oliver)	27,543	0
0.02508 %	Mc-Kay (James)	26,571	0
0.02501 %	Rodrigues (B)	26,500	26,500
0.02387 %	Moukheibir (Catherine)	25,287	0
0.02360 %	Bank Vontobel AG (Private Banking)	25,000	25,000
0.02292 %	Maybury (Andrew Leighton)	24,279	1,190
0.02237 %	University of Massachusetts Medical School	23,698	0
0.02223 %	Toomey (J J)	23,547	903
0.02192 %	State Street Global Advisors Ireland Limited	23,218	-6,088
0.02128 %	Brown (Rebecca Ann)	22,540	0
0.02110 %	Yogarajah (Sinnappah)	22,358	0
0.02060 %	Harvey (Richard)	21,820	0
0.02050 %	Glass (Clive)	21,721	0
0.02007 %	Royal London Asset Management Ltd.	21,264	0
0.01980 %	Chesworth (David)	20,972	0
0.01888 %	Holmes (L)	20,000	-100

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Cabaletta Bio	공급업체고객	0,74	0,23	0,79	0,74	0,92	0,38
Orchard Therapeutics ADR	공급업체고객	0,68	0,88	0,95	0,94	0,70
Beam Therapeutics	공급업체고객	0,63	0,69	0,91	0,82	0,89	0,72
Microsoft	공급업체고객	0,53	0,44	0,43	0,89	0,02	0,36
Novartis	공급업체고객	0,47	0,63	-0,86	-0,72	-0,19	-0,10
Liontrust Asset Mgmt	공급업체고객	0,45	0,87	0,86	0,98	0,93	0,88
AstraZeneca	공급업체고객	0,40	0,67	-0,50	-0,80	-0,68	-0,26
Sio Gene Therapies	공급업체고객	0,19	0,37	0,87	0,96	0,91	0,16
Bristol-Myers Squibb	공급업체고객	0,17	-0,42	-0,62	-0,92	-0,77	-0,41
M&G	공급업체고객	0,17	0,41	0,09	-0,52	-0,15	0,29

What values and corporate philosophy does Oxford Biomedica represent?

Oxford BioMedica PLC, a leading gene and cell therapy company, represents values of innovation, collaboration, and scientific excellence. With a corporate philosophy focused on advancing transformative treatments, Oxford BioMedica is committed to improving the lives of patients worldwide. The company's dedication to pioneering research and development is evident in their exceptional product portfolio and collaborations with top-tier partners. Oxford BioMedica PLC strives to deliver cutting-edge therapies that address unmet medical needs, leveraging its expertise in lentiviral vector and high-quality manufacturing. As a result, Oxford BioMedica PLC continues to establish itself as a trusted name in the biopharmaceutical industry, driving advancements in gene and cell therapies.

In which countries and regions is Oxford Biomedica primarily present?

Oxford BioMedica PLC is primarily present in the United Kingdom. With its headquarters in Oxford, the company operates within the region and has a strong base in the country. As a leading biopharmaceutical company, Oxford BioMedica PLC focuses on innovative gene and cell therapies, advancing the field of medicine. While the company's presence expands globally through collaborations and partnerships, its primary focus remains in the UK, contributing to the advancement of healthcare within the local market.

What significant milestones has the company Oxford Biomedica achieved?

Oxford BioMedica PLC has achieved several significant milestones. The company has successfully developed and commercialized gene and cell therapies, making significant progress in the field of gene and cell therapy. Oxford BioMedica has achieved regulatory approvals for its innovative products, such as the approval of its CAR-T therapy called Kymriah™ by the U.S. Food and Drug Administration. Furthermore, the company has also established collaborations with major pharmaceutical companies, including Novartis and Sanofi, to further advance its gene and cell therapy platform. These achievements have solidified Oxford BioMedica PLC's position as a leader in the development of gene and cell therapies, driving innovation and creating value in the biopharmaceutical industry.

What is the history and background of the company Oxford Biomedica?

Oxford BioMedica PLC is a renowned biopharmaceutical company with a rich history and background. Established in 1995, the company specializes in gene and cell therapy research and development. With its headquarters in Oxford, United Kingdom, Oxford BioMedica has gained global recognition for its innovative therapies and collaborations with major pharmaceutical companies. The company has a strong track record in gene therapy manufacturing and has successfully brought multiple therapies to market. With its dedicated team of scientists and cutting-edge technologies, Oxford BioMedica continues to pave the way in advancing gene and cell therapy for the betterment of patients worldwide.

Who are the main competitors of Oxford Biomedica in the market?

The main competitors of Oxford BioMedica PLC in the market include companies such as Novartis AG, Johnson & Johnson, and Bluebird Bio Inc.

In which industries is Oxford Biomedica primarily active?

Oxford BioMedica PLC is primarily active in the biotechnology and healthcare industries. As a leading gene and cell therapy company, Oxford BioMedica focuses on developing and commercializing innovative therapies for the treatment of serious diseases. Their expertise lies in the areas of lentiviral vector delivery systems and manufacturing processes, enabling the production of gene and cell therapies. With their cutting-edge technologies and partnerships with pharmaceutical companies, Oxford BioMedica is at the forefront of advancing medical solutions and improving patient outcomes in the biotechnology and healthcare sectors.

What is the business model of Oxford Biomedica?

The business model of Oxford BioMedica PLC is focused on the development and commercialization of innovative gene and cell therapies. With a strong emphasis on lentiviral vectors, the company aims to transform the treatment of various diseases by delivering life-changing medicines to patients in need. Oxford BioMedica PLC collaborates with pharmaceutical partners, providing them with its proprietary LentiVector® platform to develop potential therapies. By leveraging its expertise in gene and cell therapy, Oxford BioMedica PLC is dedicated to advancing breakthrough treatments and improving healthcare outcomes for patients globally.

Oxford Biomedica 2025의 P/E 비율은 얼마입니까?

Oxford Biomedica에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Oxford Biomedica 2025의 KUV는 얼마입니까?

Oxford Biomedica에 대한 현재 KUV는 계산할 수 없습니다.

Oxford Biomedica의 AlleAktien 품질 점수는 얼마인가요?

Oxford Biomedica에 대한 AlleAktien 품질 점수는 5/10입니다.

Oxford Biomedica 2025의 매출은 얼마인가요?

예상되는 Oxford Biomedica 매출은 172.23 백만 GBP입니다.

Oxford Biomedica 2025의 이익은 얼마인가요?

예상되는 Oxford Biomedica 이익은 -26.13 백만 GBP입니다.

Oxford Biomedica은 무엇을 하나요?

Oxford BioMedica PLC is an innovative biopharmaceutical company specializing in the development and manufacturing of gene therapy products. The company's business model focuses on licensed programs, proprietary programs, and services. Oxford BioMedica licenses its technology platform and manufacturing capabilities to leading biopharmaceutical companies for the development of customized gene therapies. The company also develops and markets its own gene therapy products, with a focus on treating rare diseases. Additionally, Oxford BioMedica offers contract research services along the entire value chain of gene therapy development. The company's main product is the LentiVector technology platform, which utilizes recombinant lentiviruses for efficient gene transfer. Oxford BioMedica is expanding its manufacturing capacity with new facilities in the United States.

Oxford Biomedica 배당금은 얼마입니까?

Oxford Biomedica은(는) 연간 번의 배당을 통해 0 GBP의 배당금을 지급합니다.

Oxford Biomedica이 얼마나 자주 배당을 지급하나요?

Oxford Biomedica의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Oxford Biomedica ISIN이 무엇입니까?

Oxford Biomedica의 ISIN은 GB00BDFBVT43입니다.

Oxford Biomedica WKN은 무엇인가요?

Oxford Biomedica의 WKN은 A2JLRX입니다.

Oxford Biomedica 티커는 무엇인가요?

Oxford Biomedica의 티커는 OXB.L입니다.

Oxford Biomedica이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Oxford Biomedica은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Oxford Biomedica은(는) 0 GBP의 배당금을 지급할 것으로 예상됩니다.

Oxford Biomedica의 배당 수익률은 얼마입니까?

Oxford Biomedica의 현재 배당 수익률은 입니다.

Oxford Biomedica의 배당금은 언제 지급되나요?

Oxford Biomedica은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Oxford Biomedica의 배당금은 얼마나 안전한가요?

Oxford Biomedica은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Oxford Biomedica의 배당금은 얼마입니까?

향후 12개월 동안 0 GBP의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Oxford Biomedica이(가) 속해 있는 섹터는 어디인가요?

Oxford Biomedica은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Oxford Biomedica kaufen, um die vorherige Dividende zu erhalten?

Oxford Biomedica의 마지막 배당금을 0 GBP만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Oxford Biomedica의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Oxford Biomedica의 2024년도 배당금은 얼마였습니까?

2024년에 Oxford Biomedica는 0 GBP를 배당금으로 지급했습니다.

Oxford Biomedica는 어떤 화폐로 배당금을 지급하나요?

Oxford Biomedica의 배당금은 GBP에 지급됩니다.

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.7	1.5	3.6	3	11.6	32.6	21	31.8	22.4	43.8	28.5	38.1	21.9	25.3	12.3	14.3	14.1	9.36	0	0	15.34	14.33	32.24	16.24	46.74	108.94	141.29	103.72
0	0	0	0	0	0	0	0	0.2	0.2	0.5	0.1	0.1	2	1.8	0.2	0.7	8.53	0	0	4.89	14.39	24.29	26.17	43.72	35.95	45.01	13.34
0	0	0.3	0.2	0.8	0	0	1.7	2.4	2.1	3.3	4.2	6.9	2.7	1.5	2.7	2.2	4.27	0	0	4.57	3.54	4.3	7.45	7.7	6.15	12.59	7.04
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.71	0	0	2.2	3.33	4.25	2.58	6.91	9.52	12.63	12.87
0	0.1	0.1	0.2	0.3	0.4	0.7	0.7	0.7	0.6	0.8	3	2.5	2.1	2.9	1.5	0.7	0.85	0	0	0.45	1.39	0.84	4.49	2.87	3.28	4	4.36
0.7	1.6	4	3.4	12.7	33	21.7	34.2	25.7	46.7	33.1	45.4	31.4	32.1	18.5	18.7	17.7	25.71	0	0	27.44	36.98	65.93	56.94	107.95	163.84	215.5	141.33
0	1	0.9	0.8	1.3	3.6	3.4	2.3	1.2	0.8	0.8	0.8	0.7	0.6	0.6	4.2	3.9	24.4	0	0	27.51	25.37	31.79	61.93	72.3	69.73	133.78	75.69
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.66	2.95	10.97	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	3.61	3.61	3.61	5.01	4.34
0.5	0.4	0.4	0.3	0.3	0.2	0.2	0.1	0.1	1.6	1.7	14.9	11.1	11.1	6.7	3.1	2.9	1.74	0	0	1.33	0.1	0.12	0.1	0.07	0.05	105.23	30.98
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	661	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	359	0	0	0	0
0.5	1.4	1.3	1.1	1.6	3.8	3.6	2.4	1.3	2.4	2.5	15.7	11.8	11.7	7.3	7.3	6.8	26.14	0	0	29.5	28.42	46.47	65.99	75.98	73.39	244.68	111.01
1.2	3	5.3	4.5	14.3	36.8	25.3	36.6	27	49.1	35.6	61.1	43.2	43.8	25.8	26	24.5	51.85	0	0	56.94	65.4	112.4	122.93	183.93	237.23	460.18	252.34

0.5	0.6	1.2	1.4	1.7	2.4	2.4	3.7	3.7	5	5	5.3	5.4	5.4	5.4	9.4	14.2	25.74	0	0	30.88	31.08	33.03	38.42	41.16	43.09	48.13	48.4
0	4.5	9.6	12.5	26.4	58.7	58.8	78	78.3	106.1	106.7	109.1	109.7	110	110.4	124.8	130.3	141.68	0	0	154.04	154.22	172.07	222.62	258.02	307.77	379.95	380.33
600	-2,300	-6,000	-10,200	-15,200	-23,600	-35,600	-46,500	-57,200	-64,500	-81,000	-81,900	-91,100	-93,800	-103,600	-115,800	-124,100	-156,422	0	0	-172,198	-179,154	-170,367	-185,404	-186,432	-163,515	-223,432	-354,730
0	0	0	0	0	0	0	0	0	0	-0.6	-0.6	-0.7	-0.7	-0.7	-0.7	-0.7	0	-0.68	0	0	0	0	0	0	2.29	6.65	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.1	2.8	4.8	3.7	12.9	37.5	25.6	35.2	24.8	46.6	30.1	31.9	23.3	20.9	11.5	17.7	19.7	11	-0.68	0	12.72	6.15	34.74	75.63	112.75	189.63	211.3	74.01
0.1	0.2	0.1	0.3	0.4	0.6	0.4	0.3	0.4	0.4	1.6	2.9	3.3	2	1.3	1.2	0.9	3.59	0	0	1.58	3.68	3.75	7.31	7.78	5.26	13.6	6.05
0.1	0.2	0.3	0.5	0.9	1.1	0.9	1.2	1.4	1.7	3.1	6.6	7.3	5.7	2.6	2	1.8	5.7	0	0	4.43	5.01	7.68	6.99	11.94	13.8	22.98	11.75
0	0	0	0	0	0	0	0	0	0.2	0.2	11.6	4.6	5.6	5.3	4.4	1.6	3.88	0	0	3.31	13.07	17.08	14.16	28.26	13.4	19.79	22.86
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.48	4.48	0.85	3.3	3.65
0.2	0.4	0.4	0.8	1.3	1.7	1.3	1.5	1.8	2.3	4.9	21.1	15.2	13.3	9.2	7.6	4.3	13.17	0	0	9.32	21.76	28.51	28.94	52.46	33.31	59.66	44.32
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.26	0	0	34.39	36.86	41.15	7.91	9.37	8.49	110.99	107.8
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.28	0.36	0	0	5.59	0
0	0	0	0	0	0	0	0	0.5	0.4	0.6	8.1	4.7	9.7	4.8	0.7	0.5	0.53	0	0	0.62	0.63	7.72	10.09	9.36	8.1	47.75	22.39
0	0	0	0	0	0	0	0	0.5	0.4	0.6	8.1	4.7	9.7	4.8	0.7	0.5	27.79	0	0	35.01	37.49	49.15	18.36	18.73	16.58	164.33	130.19
0.2	0.4	0.4	0.8	1.3	1.7	1.3	1.5	2.3	2.7	5.5	29.2	19.9	23	14	8.3	4.8	40.96	0	0	44.33	59.26	77.66	47.3	71.18	49.89	223.99	174.51
1.3	3.2	5.2	4.5	14.2	39.2	26.9	36.7	27.1	49.3	35.6	61.1	43.2	43.9	25.5	26	24.5	51.95	-0.68	0	57.04	65.4	112.4	122.93	183.93	239.52	435.29	248.51

Scope 1 - 직접 방출	885.65
스코프 2 - 구매한 에너지로부터의 간접적인 배출	2,801.5
Scope 3 - 가치 창출 체인 내의 간접 배출	1,767.78
총 CO₂ 배출량	3,687.15
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	54
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Oxford Biomedica 티커
프랑크푸르트	OXOA.F
LONDON	OXB.L
LONDON STOCK EXCHANGE	OXB.L
뮌헨	OXOA.MU

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
0	0	0	0	0	0	0	0	0	0	0	7	18	19	11	7	7	5	13	15	27	37	66	64	87	142	139	89	133	172	218	240	253
-	-	-	-	-	-	-	-	-	-	-	-	157.14	5.56	-42.11	-36.36	-	-28.57	160.00	15.38	80.00	37.04	78.38	-3.03	35.94	63.22	-2.11	-35.97	49.44	29.32	26.74	10.09	5.42
-	-	-	-	-	-	-	-	-	-	-	85.71	94.44	94.74	100.00	100.00	100.00	80.00	69.23	66.67	55.56	51.35	66.67	43.75	52.87	57.75	49.64	43.82	29.32	22.67	17.89	16.25	15.42
0	0	0	0	0	0	0	0	0	0	0	6	17	18	11	7	7	4	9	10	15	19	44	28	46	82	69	39	0	0	0	0	0
0	-2	-3	-4	-5	-8	-11	-10	-10	-9	-17	-15	-10	-3	-10	-12	-8	-11	-8	-13	-16	-9	7	-16	-6	19	-39	-157	-43	-26	-4	39	-5
-	-	50.00	33.33	25.00	60.00	37.50	-9.09	-	-10.00	88.89	-11.76	-33.33	-70.00	233.33	20.00	-33.33	37.50	-27.27	62.50	23.08	-43.75	-177.78	-328.57	-62.50	-416.67	-305.26	302.56	-72.61	-39.53	-84.62	-1,075.00	-112.82
2.04	2.04	3.9	5.02	5.91	7.2	7.84	5.84	7.92	8.04	10.55	11.14	11.33	11.42	10.88	18.7	22.93	28.32	40.39	51.4	55.56	61.91	69.24	72.71	79.94	85.64	94.83	96.56	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	-3	-3	-4	-5	-11	-14	-12	-12	-9	-19	-17	-12	-5	-11	-14	-10	-12	-10	-14	-11	-5	13	-14	-5	19	-45
0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	1	1	1	3	4	4	5	9	12	26
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	1	2	1	1	1	4	24	-7	7	-6	-2	0	0	3	-1	5	4	1	1	-5	-11	5
0	0	0	0	0	0	0	0	0	0	-1	-1	3	0	4	3	0	0	0	0	0	0	-6	4	4	5	1
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	10	4	2	0	0	7
0	0	0	0	0	0	0	-1,000	0	0	0	-2,000	-2,000	-1,000	-2,000	1,000	-1,000	-1,000	-1,000	-3,000	-4,000	-4,000	-3,000	-3,000	-7,000	0	0
0	-2	-3	-3	-4	-8	-10	-9	-9	-7	-15	6	-15	3	-12	-12	-10	-11	-6	-13	-1	2	12	-3	3	25	-12
0	-1	0	0	0	-3	-1	0	0	0	0	0	0	0	0	-3	0	0	-5	-16	-6	-1	-10	-25	-13	-9	-16
0	0	0	0	-11	-24	10	-11	9	-6	2	-3	12	-5	12	-5	1	4	-5	-16	-6	-1	-10	-19	-10	-9	-56
0	0	0	0	-11	-21	11	-11	9	-6	3	-3	13	-4	12	-1	2	5	0	0	0	0	0	6	2	0	-40
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	24	0	8	0	-44	-1	-4	32
0	5	6	3	14	36	0	22	0	29	0	0	0	0	0	20	11	0	24	0	19	0	21	55	41	51	80
0	4	5	3	14	32	0	20	0	29	0	0	0	0	0	18	10	0	23	24	14	-2	15	6	38	46	98
-	-	-	-	-	-3.00	-	-1.00	-	-	-	-	-	-	-	-1.00	-1.00	-	-1.00	-	-5.00	-10.00	-6.00	-4.00	-1.00	-	-13.00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	1	2	0	-2	0	0	0	0	15	-12	2	-2	-1	0	0	2	-6	12	-4	5	-1	17	-16	30	62	32
-0.02	-3.74	-3.64	-3.72	-5.58	-11.91	-11.65	-9.63	-9.8	-7.66	-15.88	5.88	-16.9	3.02	-13.39	-16.63	-10.71	-11.96	-11.61	-29.83	-8.31	1.01	2.72	-29.28	-10.24	15.99	-28.91
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Oxford Biomedica 티커	Oxford Biomedica FIGI
OXB:LN	BBG000BMB7T9
OXOA:GR	BBG000CK36M0
OXOA:GF	BBG000CK37F6
OXOA:GS	BBG000CK38D6
OXOA:GM	BBG000CK38R1
OXOA:GB	BBG000CK3917
OXBDF:US	BBG000D0PWT5
OXBDF:PQ	BBG000D0R5S3
OXBDF:UV	BBG000D0R6Y4
OXBEUR:EO	BBG000DKJXH9
OXBEUR:E1	BBG000DKL6C0
OXBEUR:XT	BBG000DKL747
OXBEUR:XW	BBG000DKL7N6
OXBEUR:EU	BBG000DKLCG3
OXB:PZ	BBG000F0CPN8
OXB:EO	BBG000G5QMK1
OXB:XH	BBG000G5QPP9
OXB:XC	BBG000G5QQB2
OXB:XF	BBG000G5QQQ6
OXB:XE	BBG000G5RST8
OXB:XJ	BBG000G5RT16
OXB:XL	BBG000G5RTN2
OXB:XG	BBG000G5RVN7
OXB:XO	BBG000G5RW91
OXB:XS	BBG000G5RYG9
OXB:XA	BBG000G5RYS6
OXB:E1	BBG000G5RZL0
OXB:XT	BBG000G5S081
OXB:XW	BBG000G5S0H1
OXB:EU	BBG000G5S2M1
OXBGBP:EO	BBG000GL9BG4
OXBGBP:XH	BBG000GLBHD1
OXBGBP:XC	BBG000GLBJ65
OXBGBP:XF	BBG000GLBKF2
OXBGBP:XE	BBG000GLBM22
OXBGBP:XJ	BBG000GLBMK2
OXBGBP:XG	BBG000GLBNW7
OXBGBP:XO	BBG000GLBP34
OXBGBP:XS	BBG000GLBSP4
OXBGBP:XA	BBG000GLBTD5
OXBGBP:E1	BBG000GLBTM5
OXBGBP:XT	BBG000GLBVD0
OXBGBP:XW	BBG000GLBW57
OXBUSD:EO	BBG000GPNQX7
OXBUSD:E1	BBG000GPP1Z8
OXBUSD:XT	BBG000GPP2G7
OXBUSD:XW	BBG000GPP2Q6
OXBUSD:EU	BBG000GPP3L9
OXBL:S1	BBG001MBZH20
OXBL:PO	BBG002JV2ZH8
OXBEUR:XV	BBG0059176J5
OXB:XV	BBG00591KM32
OXBGBP:XV	BBG00591P7N8
OXBUSD:XV	BBG00591R3L7
OXBL:B3	BBG006T75174
OXOAD:B3	BBG006T75192
OXBL:L3	BBG006TB3C82
OXOAD:L3	BBG006TB3CB8
OXOAD:PO	BBG008H09147
OXBL:EB	BBG00CP92101
OXBL:IX	BBG00CP92NS3
OXBL:TQ	BBG00GKQW3Q4
OXB:XM	BBG00J9VPK80
OXBEUR:XX	BBG00JN74VK2
OXB:XX	BBG00JN7H7X7
OXBGBP:XX	BBG00JN7LWN8
OXBUSD:XX	BBG00JN7NRM8
OXBL:QX	BBG00M0XD9C1
OXBL:BQ	BBG00VM3P5N6
OXOAD:L1	BBG00Y92JX71
OXOA:GZ	BBG00ZSCGR71
OXOA:LA	BBG018H7YB78
OXOA:LU	BBG018J1LDT5

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커OXB.L

ISINGB00BDFBVT43

WKNA2JLRX

Oxford Biomedica 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Oxford Biomedica 주가 이력

Oxford Biomedica 주식 매출, EBIT, 이익 GB00BDFBVT43 · A2JLRX

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Oxford Biomedica 매출, 이익 및 EBIT 역사

Oxford Biomedica 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Oxford Biomedica 주식 마진 GB00BDFBVT43 · A2JLRX

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Oxford Biomedica 마진 역사

Oxford Biomedica 주식 매출, EBIT, 주당 순이익 GB00BDFBVT43 · A2JLRX

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Oxford Biomedica 매출, 이익 및 EBIT 주당 역사

Oxford Biomedica 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Oxford Biomedica Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Oxford Biomedica 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Oxford Biomedica 주식 수량 GB00BDFBVT43 · A2JLRX

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Oxford Biomedica 주식 분할

한눈에 과소평가된 주식을 인식하세요.

Oxford Biomedica 수익 예상

Oxford Biomedica 수익 놀라움

Eulerpool ESG Scorecard© Oxford Biomedica 주식을 위해

Eulerpool World ESG Rating (EESG©)

73/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

티커
OXB.L

ISIN
GB00BDFBVT43

WKN
A2JLRX